MedPath

THE IMPACT OF EARLY PERCUTANEOUS TRACHEOSTOMY ON REDUCTION OF THE INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA AND THE COURSE AND OUTCOME OF ICU PATIENTS

Not Applicable
Conditions
Other postprocedural respiratory disorders
J95.8
A41.9
Sepsis, unspecified
Registration Number
DRKS00009905
Lead Sponsor
Sveucilišna klinicka bolnica MostarSpecialist of anesthesiology and reanimatology. Head of Department of anesthesiology, reanimatology and intensive care
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

The basic criterion for the inclusion in the research was the expected duration of mechanical ventilation for at least 14 days based on the diagnosis of patients sequential organ failure assessment (SOFA) score >5, acute physiology and chronic health evaluation (APACHE II) scores >10, arterial oxygen partial pressure (PaO2) =60 mmHg with fraction of inspired oxygen (FiO2) 0.5 and positive end expiratory pressure (PEEP) of at least 8 cm H2O.

Exclusion Criteria

Patients under 18 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is number of patients with aquired pneumonia that are mechanically ventilated who are going to be diagnosed based on clinical criteria (CRP value, microbiological analysis of material taken during brochoscopy, Chest x-ray, body temperature)
Secondary Outcome Measures
NameTimeMethod
Septic episodes were diagnosed based on: clinical symptoms, laboratory results, hemodynamic parameters and microbiological analysis in accordance with the usual clinical practice, as well as on the established criteria for the diagnosis of sepsis: temperature >38 °C or <36 °C, heart rate >90 beats per minute, respiratory rate >20 breaths per minute, abnormal white blood cell count >12,000/mm3 or <4,000/ mm3 or >10% bands, occurrence of hypoperfusion, hypotension and oliguria (12).
© Copyright 2025. All Rights Reserved by MedPath